Literature DB >> 4066893

Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis.

T Pincus, L F Callahan.   

Abstract

Increased mortality and morbidity was seen in association with lower formal educational levels in 75 rheumatoid arthritis (RA) patients over 9 years. Nine of the 20 patients with 8 or fewer years of education had died, compared to 10 of 34 with 9-12 years of education, and only one of 21 with more than 12 years of education. Among survivors with functional capacity data available from baseline and 9 year review, declines greater than 20% were seen in 8 of 10, 13 of 21, and 9 of 19 patients in the three education categories. Overall, 79% of grade-school educated, 43% of high-school educated, and 20% of college-educated patients had either died or declined more than 50% in functional capacity. Patients of different formal educational levels were similar at baseline in age, duration of disease, measures of functional capacity, number of involved hand joints, number of severe radiographic changes, use of gold, oral corticosteroids or other therapies, and associations between formal educational level and disease course are not explained by these variables. Formal educational level appears a simple quantitative marker which identifies a surrogate or composite variable associated with increased mortality and morbidity in RA.

Entities:  

Mesh:

Year:  1985        PMID: 4066893     DOI: 10.1016/0021-9681(85)90095-5

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  38 in total

1.  The natural history and risk factors of musculoskeletal conditions resulting in disability among US Army personnel.

Authors:  Andrew E Lincoln; Gordon S Smith; Paul J Amoroso; Nicole S Bell
Journal:  Work       Date:  2002

2.  Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis.

Authors:  J P Leigh; J F Fries
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

3.  Health status, activity limitations, and disability in work and housework among Latinos and non-Latinos with arthritis: an analysis of national data.

Authors:  Ana F Abraído-Lanza; Kellee White; Adria N Armbrister; Bruce G Link
Journal:  Arthritis Rheum       Date:  2006-06-15

Review 4.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

5.  The stability of health status in rheumatoid arthritis: a five-year study of patients with established disease.

Authors:  R F Meenan; L E Kazis; J J Anderson
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

6.  Social determinants and osteoarthritis outcomes.

Authors:  My-Linh N Luong; Rebecca J Cleveland; Kirsten A Nyrop; Leigh F Callahan
Journal:  Aging health       Date:  2012-08-01

Review 7.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

8.  Limited educational attainment and radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis using data from the Johnston County (North Carolina) Osteoarthritis Project.

Authors:  Leigh F Callahan; Jack Shreffler; Bernadette C Siaton; Charles G Helmick; Britta Schoster; Todd A Schwartz; Jiu-Chiuan Chen; Jordan B Renner; Joanne M Jordan
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

9.  Effect of education, occupation and some lifestyle factors on common rheumatic complaints in a Swedish group aged 50-70 years.

Authors:  L Jacobsson; F Lindgärde; R Manthorpe; K Ohlsson
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

10.  Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Authors:  T Sokka; H Kautiainen; T Pincus; S Toloza; G da Rocha Castelar Pinheiro; J Lazovskis; M L Hetland; T Peets; K Immonen; J F Maillefert; A A Drosos; R Alten; C Pohl; B Rojkovich; B Bresnihan; P Minnock; M Cazzato; S Bombardieri; S Rexhepi; M Rexhepi; D Andersone; S Stropuviene; M Huisman; S Sierakowski; D Karateev; V Skakic; A Naranjo; E Baecklund; D Henrohn; F Gogus; H Badsha; A Mofti; P Taylor; C McClinton; Y Yazici
Journal:  Ann Rheum Dis       Date:  2009-07-30       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.